Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells

Anxo Rio-Vilariño; Aiora Cenigaonandia-Campillo; Ana García-Bautista; Pedro A Mateos-Gómez; Marina I Schlaepfer; Laura Del Puerto-Nevado; Oscar Aguilera; Laura García-García; Carlos Galeano; Irene de Miguel; Juana Serrano-López; Natalia Baños; María Jesús Fernández-Aceñero; Juan Carlos Lacal; Enzo Medico; Jesús García-Foncillas; Arancha Cebrián

doi:10.1038/s41416-024-02667-x

Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells

Br J Cancer. 2024 May;130(8):1414. doi: 10.1038/s41416-024-02667-x.

Authors

Anxo Rio-Vilariño¹, Aiora Cenigaonandia-Campillo¹, Ana García-Bautista¹, Pedro A Mateos-Gómez², Marina I Schlaepfer¹, Laura Del Puerto-Nevado¹, Oscar Aguilera¹, Laura García-García¹, Carlos Galeano³, Irene de Miguel², Juana Serrano-López⁴, Natalia Baños⁵, María Jesús Fernández-Aceñero⁶, Juan Carlos Lacal^{7

8}, Enzo Medico^{9

10}, Jesús García-Foncillas¹¹, Arancha Cebrián¹²

Affiliations

¹ Translational Oncology Division, Oncohealth Institute, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Fundación Jiménez University Hospital (IIS-FJD, UAM), Madrid, Spain.
² Biochemistry and Molecular Biology Unit, Department of System Biology, School of Medicine and Health Sciences, University of Alcalá. Alcalá de Henares, Madrid, Spain.
³ Pathology Department, IIS-Fundación Jiménez Diaz-UAM, Madrid, Spain.
⁴ Experimental Hematology Lab, IIS-Fundación Jimenez Díaz, UAM, Madrid, Spain.
⁵ Preclinical program START Madrid-FJD, Hospital Fundación Jiménez Díaz-UAM, Madrid, Spain.
⁶ Department of Pathology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
⁷ Instituto de Investigaciones Biomédicas, CSIC/UAM, Madrid, Spain.
⁸ Instituto de Investigación Sanitaria Hospital La Paz, IDIPAZ, Madrid, Spain.
⁹ Department of Oncology, Università degli Studi di Torino, Candiolo (TO), Italy.
¹⁰ Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy.
¹¹ Translational Oncology Division, Oncohealth Institute, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Fundación Jiménez University Hospital (IIS-FJD, UAM), Madrid, Spain. jgfoncillas@fjd.es.
¹² Translational Oncology Division, Oncohealth Institute, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Fundación Jiménez University Hospital (IIS-FJD, UAM), Madrid, Spain. arancha.cebrian@quironsalud.es.

No abstract available

Publication types

Published Erratum